Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: neuroscience

Today, dementia affects over 46 million people worldwide, by 2050 it will affect more than 131 million people.

Global costs of dementia are estimated at $818 billion. As a result, if dementia care were a country, it would be the world’s 18th largest economy.

Dementias are one of the most expensive diseases for the healthcare system as patients require long-term care with daily activities like washing, getting dressed and eating. It has been estimated that the US health care would save an astonishing 40 billion dollars annually if the age of onset for Alzheimer’s disease was delayed by just 5 years. The estimated annual cost of dementia worldwide is 818 billion dollars, more than the current US defence budget. By 2018 the cost may reach a trillion dollars. Remarkably, if dementia were a country, it would be the 18th largest economy on earth.

Read more

A Harvard medical pioneer calls it “astounding” — an “incredible achievement” and a “quantum leap forward” in the battle against cancer, autism, Parkinson’s and Alzheimer’s.

What’s going on? Scientists at Ohio State University say they’ve figured out a way to grow the genetic equivalent of a nearly complete embryonic human brain.

Read more

This neural dust sprinkled into an individual’s brain tissue could form an “implantable neural interface system that remains viable for a lifetime.”

Earlier this month, five researchers at the University of California, Berkeley, put out a paper discussing the possible development of mind-reading “neural dust,” which could be implanted directly into the human brain to allow people to interact with machines.

The paper is what the MIT Technology Review calls a theoretical study: The idea is “littered with challenges beyond the state-of-the-art.”

But according to the Berkeley team, this neural dust sprinkled into an individual’s brain tissue could form an “implantable neural interface system that remains viable for a lifetime.”

Read more

An article written by Dr Michael Fossel talking about telomerase therapy for Alzheimer’s and the work Bioviva and Telocyte are doing to beat this horrific condition.

Reversing Alzheimer’s by Lengthening Telomeres.

There are telomere lengthening compounds available right now for use in research labs. They are not currently available for human use. A group of scientists wants to test these compounds on aging humans now to see if the telomere lengthening effects will induce meaningful age reversal effects.

Telomeres in our cells shorten as we grow older and create cellular havoc that predisposes us to multiple age-related pathologies. These experimental enzymes promote telomere lengthening and in the process offer an intriguing opportunity to circumvent biological aging processes.

Alzheimer’s disease has no cure and evidence points at microglial epigenetic changes being the cause of the inability to remove misfolded proteins in neurons. This proposed study will evaluate the effect the use of hTERT (human telomerase reverse transcriptase) to reverse biomarkers and symptomatology of aging with special target of the microglia cells in Alzheimer’s patients. Misfolded beta amyloids can be effectively cleared by healthy microglia. This could represent a clinical breakthrough in Alzheimer’s treatment that would be immediately available in the clinical setting.

How Alzheimer’s Can Be Prevented and Cured…

Michael Fossel, MD, PhD

As I said in my medical textbook on aging, “If age is a thief, then the greatest treasure we lose is ourselves.”

Read more

[From CNN]

Human ‘mini brains’ grown in labs may help solve cancer, autism, Alzheimer’s

mini_brain

Story highlights

  • Ohio State biomedical research team grows nearly complete human ‘mini brain’
  • Brain organoids can be used to learn more about diseases like cancer, Alzheimer’s and Parkinson’s
  • Brain organoids could yield autism breakthrough within 10 years, researcher says

By Thom Patterson | Video Source: CNN
Read the full story CNN…

Ray Kurzweil’s singularity of human superintelligence is a polar opposite of the singularity described by Vinge, Hawking, and Bostrom:

“The singularity will be a merger of our bodies and minds with our technology. The world will still be human, but transcend our biological roots. There will be no distinction between human and machine, nor between physical and virtual reality.”

Dear readers,

This month celebrates the 10 year anniversary of the classic book The Singularity Is Near, written by Ray Kurzweil, published in September 2005.

In the decade since its publication, we’ve witnessed an explosion of breakthroughs in genetic engineering, medical regeneration of the human body, autonomous robotics, computing power, and renewable energy. Advanced sensor arrays and internet meshes are uniting all people and things within the interconnected environments we live in, and with each other. Today’s massively scaled, crowd-sourced knowledge, innovation, and shared human experience are driving this momentum. The future is now.

Read more

Memory loss is a truly devastating part of dementia, but this invention aims to fix that by bypassing the damage, and repairing long term memory.

Alzheimer’s and dementia are complex diseases, and there’s currently no effective treatment. Given the unpleasant nature of the disease, there’s an urgent need for results. Instead of taking the usual biological route, one team has constructed a prosthetic made up of a small electrode array — which can help re-encode short term memory into long term.

Built using decades of research, the device operates using a new algorithm based on accumulated neural data. New sensory information is normally translated into a quick memory and transported as an electrical signal through the hippocampus, potentially for long term storage. If this region is damaged then the process is disturbed, and new experiences fail to be encoded. Alzheimer’s patients can often remember childhood events, but struggle with recent experiences; specifically because of this hippocampal damage.

Read more

Could discovering how neural stem cells protect themselves from damage lead to treatment that helps combat aging?

We now know that stem cells in the brain do in fact divide, and that this regenerative capacity begins to falter with age. The majority of our cells don’t divide, and the bulk of division falls to stem cell niches dotted across our body. Stem cell populations do age, but they’re more resistant than ‘normal’ cells are, and they produce higher levels of telomerase — enabling them to divide for years.

How do brain stem cells remain free of damage?

Neural stem cells aren’t perfectly protected from aging, but they’re generally a hardier bunch. Scientists from the University of Zurich have now discovered that part of this aging resistance in neural stem cells is due to a ‘diffusion barrier’. When they divide, these cells produce a barrier which filters out damaged proteins to one side, allowing the new cell to be damage-free.

Read more